(Q24240630)

inferred from title

cervix uterine cancer

1 reference

2

Jayne Tierney

Jayne

Tierney

1 reference

26 October 2023

Larysa Rydzewska

1

Larysa

Rydzewska

1 reference

20091632

26 October 2023

Claire L Vale

series ordinal

3

author given names

Claire L

author last names

Vale

1 reference

20091632

26 October 2023

Paul R Symonds

series ordinal

4

author given names

Paul R

author last names

Symonds

1 reference

20091632

Cochrane Database of Systematic Reviews

26 October 2023

publication date

20 January 2010

0 references

published in

0 references

cites work

Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Burden of cervical cancer in Europe: estimates for 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous c

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

A highly sensitive search strategy for clinical trials in Literatura Latino Americana e do Caribe em Ciências da Saúde (LILACS) was developed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Concomitant and neoadjuvant chemotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Aggregate data meta-analysis with time-to-event outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021

Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021

Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021

Accelerated decline in cervical cancer mortality in England and Wales

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021

Recent cancer trends in the United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021

Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007406.PUB2

7 January 2021